Crucell and Aeras initiate Phase I tuberculosis vaccine trial in ... - Pharmaceutical Business Review
Crucell and Aeras initiate Phase I tuberculosis vaccine trial in ... - Pharmaceutical Business Review - Crucell and Aeras initiate Phase I tuberculosis vaccine trial in ...Pharmaceutical Business ReviewBy Datamonitor staff writer Netherlands-based biopharmaceutical company Crucell and the Aeras Global TB Vaccine Foundation have initiated a Phase I clinical trial in infants of the jointly developed tuberculosis vaccine candidate, AERAS-402/Crucell ...New tuberculosis vaccine begins trial in South Africa TropIKAOxford researchers test TB vaccine Cherwell Onlineall 3 news articles [Google TB NEWS]
- Editor's blog
- Login or register to post comments


